Highlights
KLSE: GLOTEC (5220)       GLOBALTEC FORMATION BERHAD MAIN : Industrial Products
Last Price Today's Change   Day's Range   Trading Volume
0.44   +0.04 (10.00%)  0.40 - 0.445  9,435,500
Analyze this stock with MQ Trader system

Financials


Market Cap: 118 Million

Market Cap 118 Million
NOSH 269 Million

Latest Audited Result:  30-Jun-2020

Latest Audited Result: 30-Jun-2020
Announcement Date 30-Oct-2020
Next Audited Result: 30-Jun-2021
Est. Ann. Date: 30-Oct-2021
Est. Ann. Due Date: 27-Dec-2021

Latest Quarter:  30-Sep-2020 [#1]

Latest Quarter: 30-Sep-2020 [#1]
Announcement Date 27-Nov-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 27-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   893.06%  |    437.57%

Annual (Unaudited) ( EPS: 0.87, P/E: 50.43 )

Revenue | NP to SH 164,447  |  2,348
RPS | P/RPS 61.11 Cent  |  0.72
EPS | P/E | EY 0.87 Cent  |  50.43  |  1.98%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.89  |  0.50
YoY   112.15%
NP Margin | ROE -0.67%  |  0.98%
F.Y. | Ann. Date 30-Jun-2020  |  27-Aug-2020

T4Q Result ( EPS: 4.12, P/E: 10.67 )

Revenue | NP to SH 147,829  |  11,095
RPS | P/RPS 54.94 Cent  |  0.80
EPS | P/E | EY 4.12 Cent  |  10.67  |  9.37%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 0.91  |  0.48
QoQ | YoY   372.53%  |    160.70%
NP Margin | ROE 11.75%  |  4.53%
F.Y. | Ann. Date 30-Sep-2020  |  27-Nov-2020

Annualized Result ( EPS: 15.96, P/E: 2.75 )

Revenue | NP to SH 145,392  |  42,984
RPS | P/RPS 54.03 Cent  |  0.81
EPS | P/E | EY 15.96 Cent  |  2.75  |  36.30%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   1,730.66%  |    437.57%
NP Margin | ROE 55.81%  |  17.53%
F.Y. | Ann. Date 30-Sep-2020  |  27-Nov-2020



Business Performance

Business Performance (By Quarter)

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 1 / 4 25.00% 1 / 8 12.50%
Total Positive Profit Years 2 / 4 50.00% 5 / 8 62.50%
Continuous Quarters Of Positive Profit 1 / 4 25.00% 1 / 8 12.50%
Continuous Quarters Of Profit Growth 1 / 4 25.00% 1 / 8 12.50%
Continuous Quarters Of Adjusted EPS Growth 1 / 4 25.00% 1 / 8 12.50%
Total Dividend Years 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE 1.13% -0.44%
Average Net Profit Margin 9.20% -6.58%

Business Performance (By Year)

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Years Of Revenue Growth 0 / 5 0.00% 0 / 10 0.00%
Total Positive Profit Years 1 / 5 20.00% 2 / 10 20.00%
Continuous Years Of Positive Profit 1 / 5 20.00% 1 / 10 10.00%
Continuous Years Of Profit Growth 2 / 5 40.00% 2 / 10 20.00%
Continuous Years Of Adjusted EPS Growth 2 / 5 40.00% 2 / 10 20.00%
Total Dividend Years 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Dividend 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Dividend Growth 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Adjusted Dps Growth 0 / 5 0.00% 0 / 10 0.00%
Average ROE -5.03% -4.64%
Average Net Profit Margin -12.05% -8.65%

Key Result

Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 147,829 145,392 164,447 221,037 197,633
NP to SH 11,095 42,984 2,348 -14,953 -12,825
Dividend 0 - - - -
Adjusted EPS 4.12 15.96 0.87 -5.56 -4.77
Adjusted DPS 0.00 0.00 0.00 - -

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.


Growth

Growth (By Quarter)

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 81.95% -31.37% -31.37% -1.65% -19.99%
NP to Owner 893.06% 437.57% 437.57% 287.42% 1,296.66%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00%
Adj. EPS 898.00% 439.19% 439.19% 287.38% 1,295.51%
Adj. DPS 0.00% 0.00% 0.00% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

Growth (By Year)

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue -10.11% -25.20% -33.12% -11.59% -26.43% -34.22% -24.32% -16.79% -25.60%
NP to Owner 372.53% 186.51% 174.20% 1,730.66% 435.14% 387.45% 112.15% 118.31% 115.70%
Dividend 0.00% 0.00% 0.00% - % - % - % 0.00% 0.00% 0.00%
Adj. EPS 373.56% 186.43% 174.14% 1,734.48% 434.82% 387.19% 112.12% 118.25% 115.66%
Adj. DPS 0.00% 0.00% 0.00% - % - % - % 0.00% 0.00% 0.00%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Trade this stock for as low as 0.05% brokerage. Find out more.
  27 people like this.
 
hasimdaud drop from 56.5 to 43.5 fake news
19/10/2020 10:01 AM
limfly20 Cut loss , wasting time here, if buy hwgb or solution / bintai already make some profit, all price up recently
19/10/2020 1:29 PM
Lee Chee Wee Near support 0.425 wt weak selling, will rebound soon. Stay tune.
19/10/2020 3:06 PM
asd88 Been in collection mode for awhile now
20/10/2020 1:32 PM
mansaham1972 Tq glotec kasi untung segera
27/10/2020 8:21 PM
maxstore769 main2 area MA20 ni
28/10/2020 3:44 PM
cccthierry http://www.globaltec.com.my/index.php/resources/
05/11/2020 4:05 PM
maxstore769 .................
06/11/2020 10:34 AM
awesome20 related to auto industry..should get benefited from Bauto, Drbhicom price movement
15/11/2020 4:23 PM
limfly20 Dead Water, Hopeless
16/11/2020 4:07 AM
pari57 He he he agree
16/11/2020 4:44 AM
jasonysk Rubbish counter
20/11/2020 7:52 PM
mrmeow Laggard vaccine?
23/11/2020 8:08 PM
BilisMasin Scam counter
26/11/2020 11:44 AM
mrmeow Monday limit up
27/11/2020 5:39 PM
dompeilee Great set of results!!! =)
27/11/2020 5:48 PM
mrmeow Indeed, tomorrow will move upwards
29/11/2020 11:21 PM
cccthierry doing plam oil as well... https://www.globaltec.com.my/index.php/resources/
30/11/2020 9:59 AM
Pandu1 Latest net profit of 20.3mil.....
30/11/2020 10:05 AM
Pandu1 Without sales of vaccine.
30/11/2020 10:07 AM
Pandu1 Palm oil n coal mining could b the contributing profit.
30/11/2020 10:11 AM
hsyanbird GLOTEC-WA will be more profit. Seem like limit up coming today.
30/11/2020 10:57 AM
hsyanbird Good earning. Will limit up for both mother and company warrant. Bought 2000lots waiting for big profit.
01/12/2020 1:04 AM
mansaham1972 Waran plg cantik kalau dapat harga 8.5 sen.Apapun hari ini saya tetap masuk harga 9 sen sebab mother masih bertahan lebih 40 sen.
01/12/2020 7:57 PM
abc123_2020 (Kuala Lumpur, 9th) The President of the Chinese President Tan Sri Wu Tianquan said that the coronavirus vaccine developed by China is currently in the third phase of clinical trials under the UN World Health Organization. Once it has passed the market and obtained my country’s halal certification After that, it can be emergency in our country.


He said that President Hua fully supports the government's emergency response to the introduction of Chinese vaccines. In this regard, we are also prepared to cooperate with the governments of Malaysia and China and relevant parties, in accordance with all necessary regulations and regulations, to assist relevant enterprises in docking to introduce vaccines to Malaysia.

Wu Tianquan is also the president of the Chinese Assembly Hall in Sabah. He recently communicated with the leadership of the agency’s chief executive, Dr. Akma Yusuf, at the headquarters of the Malaysian Clinical Research Institute (CRM) to understand the organization’s operating procedures. In a statement issued today, it said.

According to the agency, relevant preparations have been made to introduce Chinese vaccines.

Wu Tianquan said that President Hua is also actively contacting relevant Chinese parties, hoping to assist and coordinate the introduction of approved vaccines to Malaysia, and cooperate with all departments and institutions, including Malaysian clinical research institutions, to help my country connect with enterprises. Anti-epidemic work, especially in civilian epidemic prevention.

He described that the Malaysian Clinical Research Institute was established in 2012 on the recommendation of the Malaysian Clinical Research Center (CRC), mainly to assist the government in managing overseas clinical research and to promote important work such as clinical research in my country. It is also well regulated by the National Pharmaceutical Regulatory Agency (NPRA) and the Medical Research and Ethics Committee (MREC).


At the same time, Wu Tianquan, who is also the major shareholder and executive chairman of Elite Holdings Limited (GLOTEC, 5220, main board industrial stock), a company listed on the Kuala Lumpur Stock Exchange, said that the group's subsidiaries are also discussing participation in the project of introducing Chinese vaccines, hoping to help Give corporate feedback on the national anti-epidemic work.

He said that in particular, the country is currently facing the third wave of attacks, and many regions in the country are trapped in yellow and red zones. After the implementation of the state closure and cross-county ban, the government, enterprises and businesses, including the people, must work together. Cooperate, comprehensively prevent and fight the epidemic, so as to flatten the curve as soon as possible.

"This includes arrangements for the introduction of vaccines. We hope that vaccines can be approved for market as soon as possible to resolve the crisis."

He pointed out that the Chinese government, through the Ministry of Science, Technology and Innovation, is also responsible for consulting with relevant Chinese government departments and institutions, and deciding on cooperation and procurement plans for COVID-19 vaccines. According to Carey, Minister of Science and Arts, the third phase clinical trial data of COVID-19 vaccine is expected to be analyzed by the end of this year. The department, the Ministry of Health and the General Prosecutor's Office are discussing relevant legal affairs and procurement models.
07/12/2020 11:26 AM
abc123_2020 Look like GLOTEC will come
07/12/2020 11:27 AM
hsyanbird CPO break 360.. glotec & glotec-wa will fly
08/12/2020 9:03 AM
hsyanbird Flat a few days... buy now before CPO price break 3700. This counter will fly accordingly.

Glotec-wa more profit to go. TAYOR.
10/12/2020 10:57 AM
Lim Bernard Tunggu sampai sampai leher pun mahu putus masih pun tak jalan buang lah tong sampag lebeh baik
10/12/2020 4:14 PM
jasonysk Fly in to the tong sampah...?
10/12/2020 5:11 PM
thesteward Can go very far . Esp the warrant . This one dark horse
11/12/2020 2:59 PM
IbnuShaari those who patiently waiting will see the light at the end of the dark tunnel although the journey quite long.
11/12/2020 3:06 PM
cccthierry cheater counter
11/12/2020 3:11 PM
thesteward Potential black horse
11/12/2020 3:33 PM
FutureGains Friday got some movement..Monitor monday
12/12/2020 2:54 PM
tollebunsmith if add 2 qtrs. averageu s less that normal by 30%... it is a TRAP
13/12/2020 9:36 AM
tollebunsmith write up is nonsense
13/12/2020 9:37 AM
up41 The exceptional profit for the reporting quarter was due to a Gain on disposal of gold royalty of 22m ( refer to cashflow statements) . The reporting revenue & gross profit were down .
13/12/2020 11:31 AM
awesome20 open high close with doji today
15/12/2020 6:34 PM
IbnuShaari alahai elok2 dah stabilizes 43-44c, now gone down unsupported. Seems to be intentionally blocked for further going-up. What games is this? I can't really understand!... volume remains low for the force selling cause. Who is actually liquidating? The good quarterly result makes no diff. Seems to go back where it started at 38c!
21/12/2020 6:25 PM
Lim Bernard i areadybuang in to tong sampah
22/12/2020 12:11 PM
beeair2013 Bought @0.40 ............
24/12/2020 3:53 PM
IbnuShaari Counter ni memang tak friendly. Tidurnya lebih dari jaga! kalau Jaga pun mcm orang kena gam, mamai2, lps tu terus tidur balik without wake-up!
29/12/2020 11:00 AM
IbnuShaari The counter which never given a chance to make a profit for retailers. If you buy you will get stuck indefinitely.
29/12/2020 11:19 AM
Lim Bernard tidur lah 2050
30/12/2020 11:28 PM
damansaraeagle Technically, it is not looking good for GLOTEC as its 20-Day Moving Average is sloping downward and its price action is below the Moving Average line. The recent downward movement in price has brought us to the technically important level of 0.395. Failure to find support at this level may accentuate the bearish move. The RSI indicator is giving a reading in the oversold region. This may indicate the price decline may be over-extended. The price and volume action at the 0.395 support level is to be monitored carefully.
08/01/2021 12:03 PM
stan5617 conman
19/01/2021 11:26 AM
ask1961 V quiet aa today.
20/01/2021 5:18 PM
ask1961 Nobody play glotec aa? I sold everything today after long time keeping. No movement!
20/01/2021 5:19 PM
Hew Kiong Peng George baru begin uptrend..must hold aa.net cash around 18sen limited downside n huge upside potential
20/01/2021 8:25 PM